After more than 2-months of review by the FDA committee, we are pleased to announce that Chenland’s Patented Brand Ingredient JointAlive® is the first TCM-based branded ingredients to receive a successful NDI notification (NDIN 1172).
The term “new dietary ingredient” means a dietary ingredient that was not marketed in the United States in a dietary supplement before October 15, 1994. The Federal Food, Drug, and Cosmetic Act (the FD&C Act) requires that manufacturers and distributors who wish to market dietary supplements that contain “new dietary ingredients” notify the Food and Drug Administration about these ingredients. (See Section 413(d) of the FD&C Act, 21 U.S.C. 350b(d).) The notification must include information that is the basis on which the manufacturer or distributor has concluded that a dietary supplement containing a new dietary ingredient will be expected to be safe under the conditions of use recommended or suggested in the labeling.
By successfully receiving the NDI notification, JointAlive® is FDA recognized to be safely used in dietary supplements. JointAlive® is Chenland’s premier joint support solution with clinically proven formula. It is a specially formulated botanical blend with three traditional Asian herbs: Epimedium brevicornum Maxim, Discorea nipponica Makino and Salvia miltiorrhiza Bunge. The development of JointAlive® is based on 2,000 years Traditional Chinese Medicine history and with traceability guaranteed from strict quality control throughout the entire production process.
 U.S. Food & Drug Administration. (2020.10.26). New Dietary Ingredients in Dietary Supplements Background for Industry. Retrieved from https://www.fda.gov/food/new-dietary-ingredients-ndi-notification-process/new-dietary-ingredients-dietary-supplements-background-industry